FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumors.
Briest F, Berg E, Grass I, Freitag H, Kaemmerer D, Lewens F, Christen F, Arsenic R, Altendorf-Hofmann A, Kunze A, Sänger J, Knösel T, Siegmund B, Hummel M, Grabowski P.
Briest F, et al.
Oncotarget. 2015 Apr 10;6(10):8185-99. doi: 10.18632/oncotarget.3600.
Oncotarget. 2015.
PMID: 25797272
Free PMC article.